<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

Sharon O'Reilly

Founder, President and Chief Executive Officer Founder, former President & CEO, Medtech Insight, 25+ years' experience in the Medical Device industry in Sales, Marketing, Business Development, Consulting with major manufacturers (J&J, Pfizer, US Surgical), start-up companies and business intelligence providers (Medical Data International, Windhover Information)

Wound Care

SmartTRAK Back From EWMA Wound Meeting in Amsterdam!

SmartTRAK just returned from the May 3-5, 2017 EWMA European Wound Management Association Meeting held i...

Orthopedics

Historical Controls Remove Barrier in Cartilage IDE Studies

FDA allowing use of historical controls may overcome a significant barrier and expedite pt enrollment in...

Orthopedics

Role of Injectable Therapies for Knee Osteoarthritis

Injectable treatments will never turn a bad joint into a good one but may relieve pain for an undetermin...

Orthopedics

Greater Need for Cartilage Repair in Ankle vs Knee

Ironically, there is a greater need for a cartilage replacement technology in the ankle than in the knee...

Orthopedics

Another Showdown in the Hyaluronic Acid Market?

AAOS Shifts Focus From Efficacy to Cost The American Association of Orthopedic Surgeons (AAOS) has shift...

Orthopedics

New Injectable Technologies For Knee Pain Highlighted at ICRS

Two new injectable technologies that may potentially fill the gap in treatment options for patients with...

SmartTRAK News

ConvaTec IPO Prospectus Cites BioMedGPS SmartTRAK as Source

In ConvaTec's IPO prospectus released October 26, 2016, BiomedGPS was cited 25 times as a source for the...

Orthopedics

Joint Fluid Market: New Players, New Products

With few options available for treating OA pain, joint fluid injections have become a standard part of t...

Orthopedics

Joint Fluid Market: New Players, New Products

Changing competitive landscape set to expand overall market With few options available for treating OA p...

1 2 3 4 5 6 7